Inventor · disambiguated record
Neil R. Cashman
Also filed as: CASHMAN NEIL · CASHMAN NEIL R · CASHMAN NEIL ROY · PINARD MARC
38 granted patents·29 pending applications·221 citations·filing 1998–2025
97Inventor score
Files withUNIV BRITISH COLUMBIA28PROMIS NEUROSCIENCES INC6AMORFIX LIFE SCIENCES LTD5CASHMAN NEIL R5CASHMAN NEIL3
Top patents by PatentIndex Score
67 records- 0195US7439324B2ALS-specific peptide compositionAMORFIX LIFE SCIENCES LTD·Filed 2006·Granted Oct 21, 2008·24 cites·4 claims
- 0293US10751382B2Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptideUNIV BRITISH COLUMBIA·Filed 2018·Granted Aug 25, 2020·5 cites·15 claims
- 0392US7977314B2Methods and compositions to treat and detect misfolded-SOD1 mediated diseasesAMORFIX LIFE SCIENCES LTD·Filed 2007·Granted Jul 12, 2011·17 cites·9 claims
- 0491US7794692B2Methods and compositions for detecting amyotrophic lateral sclerosisAMORFIX LIFE SCIENCES LTD·Filed 2006·Granted Sep 14, 2010·19 cites·8 claims
- 0589US10774120B2Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptideUNIV BRITISH COLUMBIA·Filed 2016·Granted Sep 15, 2020·4 cites·8 claims
- 0688US8778885B2Methods and compositions to treat and detect misfolded-SOD1 mediated diseasesCASHMAN NEIL R·Filed 2011·Granted Jul 15, 2014·12 cites·34 claims
- 0788US8075891B2Antibodies that bind ALS specific epitopes and methods of makingCASHMAN NEIL·Filed 2010·Granted Dec 13, 2011·5 cites·7 claims
- 0887US9849165B2Oligomer-specific amyloid beta epitope and antibodiesUNIV BRITISH COLUMBIA·Filed 2015·Granted Dec 26, 2017·5 cites·12 claims
- 0986US9637552B2Methods and compositions to treat and detect misfolded-SOD1 mediated diseasesPROMIS NEUROSCIENCES INC·Filed 2014·Granted May 2, 2017·9 cites·16 claims
- 1086US8709422B2Methods and compositions to treat and detect misfolded-SOD1 mediated diseasesCASHMAN NEIL R·Filed 2010·Granted Apr 29, 2014·11 cites·27 claims
- 1186US7887803B2Methods and compositions to treat misfolded-SOD1 mediated diseasesAmorfix Life Sciences·Filed 2007·Granted Feb 15, 2011·13 cites·11 claims
- 1286US7763710B2ALS-specific peptide compositionAMORFIX LIFE SCIENCES LTD·Filed 2008·Granted Jul 27, 2010·6 cites·4 claims
- 1385US9216217B2Oligomer-specific amyloid beta epitope and antibodiesCASHMAN NEIL R·Filed 2011·Granted Dec 22, 2015·7 cites·15 claims
- 1485US7041807B1Antibodies to a YYX epitope of a mammalian prion proteinCAPRION PHARMACEUTICALS INC·Filed 2000·Granted May 9, 2006·41 cites·26 claims
- 1584US8828389B2Methods of diagnosing ALSCASHMAN NEIL·Filed 2011·Granted Sep 9, 2014·2 cites·14 claims
- 1679US8513387B2Methods and compositions for detecting amyotrophic lateral sclerosisCHAKRABARTTY AVIJIT·Filed 2010·Granted Aug 20, 2013·6 cites·21 claims
- 1777US7435540B2PrPSc-selective peptidesIDEXX CORP·Filed 2006·Granted Oct 14, 2008·5 cites·16 claims
- 1871US11779629B2Compositions comprising cyclic peptides derived from an A-beta peptideUNIV BRITISH COLUMBIA·Filed 2020·Granted Oct 10, 2023·0 cites·9 claims
- 1970US9200080B2Agonistic antibodies to TrkC receptors and uses thereofSARAGOVI HORACIO URI·Filed 2010·Granted Dec 1, 2015·2 cites·20 claims
- 2069US2025051428A1Antibodies to amyloid betaUNIV BRITISH COLUMBIA·Filed 2024·Application pending·0 cites
- 2167US9625476B2Methods of diagnosing ALSPROMIS NEUROSCIENCES INC·Filed 2014·Granted Apr 18, 2017·0 cites·16 claims
- 2266US12404321B2Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereofUNIV BRITISH COLUMBIA·Filed 2019·Granted Sep 2, 2025·0 cites·18 claims
- 2366US12173055B2N-terminal epitopes in amyloid beta and conformationally-selective antibodies theretoUNIV BRITISH COLUMBIA·Filed 2020·Granted Dec 24, 2024·0 cites·16 claims
- 2466US11970522B2Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptideUNIV BRITISH COLUMBIA·Filed 2020·Granted Apr 30, 2024·0 cites·16 claims
- 2566US11905318B2Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptideUNIV BRITISH COLUMBIA·Filed 2020·Granted Feb 20, 2024·0 cites·19 claims
- 2666US9507012B2Determining the position of a mobile device within a structureHEWLETT PACKARD DEVELOPMENT CO LP·Filed 2013·Granted Nov 29, 2016·4 cites·8 claims
- 2766US2017192020A1Methods of diagnosing alsPROMIS NEUROSCIENCES INC·Filed 2017·Application pending·0 cites
- 2864US2025346655A1Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereofUNIV BRITISH COLUMBIA·Filed 2025·Application pending·0 cites
- 2964US2009175884A1Misfolded proteins in cancer treatment and diagnosisCASHMAN NEIL ROY·Filed 2008·Application pending·0 cites
- 3060US9296819B2Antibodies and conjugates that target misfolded prion proteinPROMIS NEUROSCIENCES INC·Filed 2013·Granted Mar 29, 2016·1 cites·18 claims
- 3160US2022162293A1Epitopes in the rna recognition motif 1 (rrm1) of tdp-43 and misfolding-selective antibodies theretoUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 3260US2011305630A1Misfolded proteins in cancer treatment and diagnosisCASHMAN NEIL ROY·Filed 2011·Application pending·0 cites
- 3359US10759837B2Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptideUNIV BRITISH COLUMBIA·Filed 2016·Granted Sep 1, 2020·0 cites·9 claims
- 3459US2013330275A1Misfolded proteins in cancer treatment and diagnosisCASHMAN NEIL ROY·Filed 2013·Application pending·0 cites
- 3558US2018125920A1Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditionsUNIV BRITISH COLUMBIA·Filed 2017·Application pending·0 cites
- 3657US9056918B2Prion epitopes and methods of use thereofNAPPER SCOTT·Filed 2009·Granted Jun 16, 2015·1 cites·17 claims
- 3756US12071472B2Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomersUNIV BRITISH COLUMBIA·Filed 2017·Granted Aug 27, 2024·0 cites·19 claims
- 3854US2014314773A1Compositions and methods for treating alzheimer's diseaseCANGENE U S INC·Filed 2012·Application pending·0 cites
- 3954US2018079825A1Methods and compositions to treat and detect misfolded-sod1 mediated diseasesPROMIS NEUROSCIENCES INC·Filed 2017·Application pending·0 cites
- 4053US2010233176A1Methods and systems for predicting misfolded protein epitopesCASHMAN NEIL R·Filed 2009·Application pending·0 cites
- 4152US10772969B2N-terminal epitopes in amyloid beta and conformationally-selective antibodies theretoUNIV BRITISH COLUMBIA·Filed 2016·Granted Sep 15, 2020·0 cites·17 claims
- 4252US9376476B2Prion epitopes and methods of use thereofUNIV SASKATCHEWAN·Filed 2015·Granted Jun 28, 2016·0 cites·13 claims
- 4351US11214613B2Epitopes in the RNA recognition motif 1 (RRM1) of TDP-43 and misfolding-selective antibodies theretoUNIV BRITISH COLUMBIA·Filed 2018·Granted Jan 4, 2022·0 cites·26 claims
- 4451US2023151369A1Compositions and methods for inhibiting tdp-43 and fus aggregationUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 4551US2022218805A1Conformation-specific epitopes in tau, antibodies thereto and methods related thereofUNIV BRITISH COLUMBIA·Filed 2020·Application pending·0 cites
- 4650US9809620B2Prion disease-specific epitopes and methods of use thereofUNIV SASKATCHEWAN·Filed 2014·Granted Nov 7, 2017·0 cites·17 claims
- 4750US2023141177A1Antibodies to misfolded amyloid betaUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 4849US9523697B2Detection of pathogenic abeta using an epitope protection assayCASHMAN NEIL·Filed 2010·Granted Dec 20, 2016·0 cites·9 claims
- 4949US2023174630A1Single chain antibodies and intrabodies to misfolded tdp-43 and methods of useUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 5047US10053510B2FasR antibodies and methods of usePROMIS NEUROSCIENCES INC·Filed 2014·Granted Aug 21, 2018·0 cites·13 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Neil R. Cashman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →